dbACP: A Comprehensive Database of Anti-Cancer Peptides

dbacp02999

General Description

Peptide name : GA-K4

Source/Organism : Brevinin-1EMa

Linear/Cyclic : Linear

Chirality : L

Sequence Information

Sequence : FLKWLFKWAKK

Peptide length: 11

C-terminal modification: Linear

N-terminal modification : Free

Non-natural peptide information: None

Activity Information

Assay type : MTT/MTS assay

Assay time : 72h

Activity : IC50 : 12.55 µM

Cell line : SK-OV-3

Cancer type : Ovarian cancer

Other activity : Anti-microbial activity

Physicochemical Properties

Amino acid composition bar chart :

Molecular mass : 1494.865 Dalton

Aliphatic index : 0.8

Instability index : -14.736

Hydrophobicity (GRAVY) : -0.218

Isoelectric point : 10.477

Charge (pH 7) : 3.7561

Aromaticity : 0.363

Molar extinction coefficient (cysteine, cystine): (11000, 11000)

Hydrophobic/hydrophilic ratio : 1.75

hydrophobic moment : 0.9782

Missing amino acid : C,R,H,Q,T,P,M,I,E,S,D,Y,N,V,G

Most occurring amino acid : K

Most occurring amino acid frequency : 4

Least occurring amino acid : A

Least occurring amino acid frequency : 1

Structural Information

3D structure :

Secondary structure fraction (Helix, Turn, Sheet): (0.6, 0, 0.5)

SMILES Notation: CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O

Secondary Structure :

Method Prediction
GOR HHHHHHHHHHH
Chou-Fasman (CF) HHHHHHHHCCC
Neural Network (NN) HHHHHHHHHCC
Joint/Consensus HHHHHHHHHCC

Molecular Descriptors and ADMET Properties

Molecular Descriptors: Click here to download

ADMET Properties: Click here to download

Cross Referencing databases

Pubmed Id : 22644847

Uniprot : Not available

PDB : Not available

CancerPPD : Click here

ApIAPDB : Not available

CancerPPD2 ID : Not available

Reference

1 : Kang SJ, et al. Anticancer activity of undecapeptide analogues derived from antimicrobial peptide, brevinin-1EMa. Arch Pharm Res. 2012; 35:791-9. doi: 10.1007/s12272-012-0505-0

Literature

Paper title : Anticancer activity of undecapeptide analogues derived from antimicrobial peptide, brevinin-1EMa.

Doi : https://doi.org/10.1007/s12272-012-0505-0

Abstract : In spite of great advances in cancer therapy, cancer remains the major cause of death throughout the world. The increasing resistance of cancer cells towards current anticancer drugs requires development of anticancer agents with a new mode of action. Some antimicrobial peptides have become therapeutic candidates as new anticancer agents. As part of an effort to develop new antimicrobial and/or anticancer agents from natural peptides with low molecular weights, we have investigated the shortest bioactive analogues, which were derived from a 24-residue antimicrobial peptide, Brevinin-1EMa. Recently, we found four bioactive undecapeptides derived from a cationic, amphipathic α-helical, 11-residue peptide (named herein GA-W2: FLGWLFKWASK-NH(2)) (Won et al., 2011). In order to identify the potential of these peptides as anticancer agents, we investigated the anticancer activity of four undecapeptides against seven tumor cell lines such as A498 (kidney), A549 (lung), HCT116 (colon), MKN45 (stomach), PC-3 (prostate), SK-MEL-2 (skin) and SK-OV-3 (ovary). GA-K4 (FLKWLFKWAKK-NH(2)), which had the most potent antimicrobial activity of the four undecapeptides, also exhibited the most potent anticancer activity and synergistic effect in combination with doxorubicin. Therefore, GA-K4 peptide may be a potentially useful candidate as an anticancer peptide agent.